Fig. 5From: Receptor-based pharmacophore modeling, molecular docking, synthesis and biological evaluation of novel VEGFR-2, FGFR-1, and BRAF multi-kinase inhibitorsA The selected promising scaffold 8a by Ph4-4. B The promising scaffold 8a mapped onto Ph4-4 with RMSD of 0.979ÅBack to article page